In investing, there's no need to invest in individual stocks to achieve strong returns over time. Don't get me wrong. I own about 40 different individual stocks and completely believe it's possible to beat the market over time.

With Rural Family-Owned Pubs in Ireland Facing Uncertain Future Due to Unclear Succession*, Heineken® Is Helping an Independent Publican Find a Namesake Who Wants to Reclaim Their Irish Heritage and Continue a 155-Year Legacy

MISSISSAUGA, Ontario, March 18, 2025 ( GLOBE NEWSWIRE ) -- BioSyent Inc. ( "BioSyent" or the "Company", TSX Venture: RX ) announces that its Board of Directors has approved a grant of 56,767 Restricted Share Units "RSUs" to certain directors, officers, management, and employees of the Company ...

NEW YORK, March 18, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ibotta, Inc. IBTA for potential violations of the federal securities laws.

NASA astronauts Butch Wilmore and Suni Williams are set to splash down on Earth on Tuesday evening after spending more than nine months in space.

Uncertainty has taken over the market. Business and consumer sentiment data are souring as markets tumble and tariff policy continues to lack rhyme or reason. The St Louis Fed's US Economic Policy Uncertainty Index has spiked to its highest level since December 2020.

Deep-pocketed investors have adopted a bullish approach towards Cheniere Energy LNG, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

Financial giants have made a conspicuous bullish move on MetLife. Our analysis of options history for MetLife MET revealed 11 unusual trades. Delving into the details, we found 45% of traders were bullish, while 0% showed bearish tendencies.

Investors with a lot of money to spend have taken a bullish stance on Nucor NUE. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Novo Nordisk ( NYSE: NVO ) , the Danish company best known as the maker of weight loss drug Wegovy, expanded a little on the stock exchange Tuesday. The company was one of the rare enterprises seeing an increase in price on what was generally a down day for the market.